REG - Tristel PLC - Issue of Equity
RNS Number : 9465RTristel PLC06 March 2019
Tristel plc
("Tristel" or the "Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by an employee, it has issued and allotted 17,000 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 11 March 2019.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 44,456,823 Ordinary Shares. Accordingly, the figure of 44,456,823 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Tristel plc
Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
Mob: 07854 391 303
finnCap
Tel: 020 7220 0500
Geoff Nash / Giles Rolls, Corporate Finance
Alice Lane, ECM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDIOEBIGDXLDGBGCU
Recent news on Tristel
See all newsRCS - Tristel PLC - Conference attendance at Mello2025 Investor event
AnnouncementREG - AIM - AIM Notice - 19/05/2025
AnnouncementREG - Tristel PLC - Exercise of Share Options and Total Voting Rights
AnnouncementREG - Tristel PLC - CFO succession planning
AnnouncementREG - Tristel PLC - FDA clearance for Tristel OPH
Announcement